MiR-942 decreased before 20 weeks gestation in women with preeclampsia and was associated with the pathophysiology of preeclampsia in vitro
Authors:
- 17 February 2017
- journal article
- research article
- Published by Taylor & Francis in Clinical and Experimental Hypertension
- Vol. 39 (2) , 108-113
Abstract
Objective: To investigate the possible relationship between miR-942 levels and the pathogenesis of preeclampsia using in vitro assays and to investigate circulating miR-942 levels in the early phase of mid-of pregnancy in women who later developed preeclampsia and in women with uncomplicated pregnancies. Methods: Plasma samples were collected from pregnant women between 12 and 20 weeks of gestation. MiR-942 levels were determined by stem-loop real-time PCR for 26 cases who subsequently developed preeclampsia as well as for 52 controls. Bioinformatics software was used to predict the target genes of miR-942, and a dual-luciferase reporter system was utilized to validate target gene regulation. Finally, MTT proliferation assays, transwell invasion assays, and endothelial cell tube formation assays were performed to further explore the function of miR-942 using a human extravillous trophoblast cell line (TEV-1). Result: Circulating miR-942 levels were significantly lower in mid-pregnancy (12–20 weeks gestation) in women who later developed preeclampsia compared with those with an uncomplicated pregnancy (p < 0.05). Endoglin (ENG) is an miR-942 target gene. MiR-942 had a sensitivity of 0.673, a specificity of 0.875, and an area under the receiver operating characteristic curve (AUC) of 0.718 [95% CI, 0.594–0.822] for the possible screening of preeclampsia. In vitro, decreased miR-942 expression decreased the invasive ability of TEV-1 cells, and inhibited the HUVEC angiogenesis assay, both effects that are similar to what is observed in preeclampsia (both p Conclusion: MiR-942 may be involved in the pathogenesis of preeclampsia via the regulation of its target gene ENG. Multicenter studies must be performed and a greater number of samples must be analyzed to ascertain whether circulating miR-942 levels can serve as a novel early diagnostic marker for preeclampsia.Keywords
Funding Information
- the fund of the Universities of Guangzhou (1201410026)
- the National Natural Science Fund of China (2012-81102197)
This publication has 26 references indexed in Scilit:
- Maternal Plasma miRNAs Expression in Preeclamptic PregnanciesBioMed Research International, 2013
- MicroRNA Expression Profiles of Whole Blood in Lung AdenocarcinomaPLOS ONE, 2012
- p53 Regulates Cell Cycle and MicroRNAs to Promote Differentiation of Human Embryonic Stem CellsPLOS Biology, 2012
- Hydroxysteroid (17-β) Dehydrogenase 1 Is Dysregulated by Mir-210 and Mir-518c That Are Aberrantly Expressed in Preeclamptic PlacentasHypertension, 2012
- MicroRNA-378a-5p promotes trophoblast cell survival, migration and invasion by targeting NodalJournal of Cell Science, 2012
- Non-coding RNAs in human diseaseNature Reviews Genetics, 2011
- An Early Developmental Role for miRNAs in the Maintenance of Extraembryonic Stem Cells in the Mouse EmbryoDevelopmental Cell, 2010
- Tumor necrosis factor-related apoptosis-inducing ligand and the regulation of hematopoiesisCurrent Opinion in Hematology, 2008
- MicroRNA and Lung CancerNew England Journal of Medicine, 2005
- PI‐3K/Akt and NF‐κB/IκBα pathways are activated in Jurkat T cells in response to TRAIL treatmentJournal of Cellular Physiology, 2004